Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - Other
Ratios

Altimmune (ALT) Receivables - Net (2016 - 2025)

Altimmune (ALT) has disclosed Receivables - Net for 16 consecutive years, with $1.2 million as the latest value for Q4 2025.

  • Quarterly Receivables - Net rose 124.08% to $1.2 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.2 million through Dec 2025, up 124.08% year-over-year, with the annual reading at $1.2 million for FY2025, 124.08% up from the prior year.
  • Receivables - Net for Q4 2025 was $1.2 million at Altimmune, up from $845000.0 in the prior quarter.
  • The five-year high for Receivables - Net was $4.8 million in Q1 2021, with the low at $136000.0 in Q2 2023.
  • Average Receivables - Net over 5 years is $971581.5, with a median of $468000.0 recorded in 2021.
  • The sharpest move saw Receivables - Net crashed 95.98% in 2022, then skyrocketed 542.2% in 2023.
  • Over 5 years, Receivables - Net stood at $429000.0 in 2021, then tumbled by 59.67% to $173000.0 in 2022, then surged by 542.2% to $1.1 million in 2023, then crashed by 51.04% to $544000.0 in 2024, then surged by 124.08% to $1.2 million in 2025.
  • According to Business Quant data, Receivables - Net over the past three periods came in at $1.2 million, $845000.0, and $321000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.